Clonazepam treatment of chronic schizophrenia: negative results in a double-blind, placebo-controlled trial

C. N. Karson, D. R. Weinberger, L. Bigelow, R. J. Wyatt

Research output: Contribution to journalArticlepeer-review

Abstract

Clonazepam, a potent benzodiazepine, failed to be of additional therapeutic benefit to 13 chronic schizophrenic patients already receiving neuroleptic medications. Moreover, 4 patients demonstrated violent behavior during the course of clonazepam treatment.

Original languageEnglish (US)
Pages (from-to)1627-1628
Number of pages2
JournalAmerican Journal of Psychiatry
Volume139
Issue number12
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Clonazepam treatment of chronic schizophrenia: negative results in a double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Cite this